{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:19:56Z","timestamp":1794917996154,"version":"4.9.1"},"reference-count":220,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["AHA26POST1563063"],"award-info":[{"award-number":["AHA26POST1563063"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL146691"],"award-info":[{"award-number":["R01-HL146691"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK123259"],"award-info":[{"award-number":["R01-DK123259"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03177-1","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:47:55Z","timestamp":1777456075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cardiovascular\u2013kidney\u2013metabolic syndrome: a comprehensive review of pathophysiology, epidemiology, diagnosis, and management"],"prefix":"10.1186","volume":"25","author":[{"given":"Stanislovas S.","family":"Jankauskas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Komici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Varzideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Simone","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urna","family":"Kansakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"D\u2019Onghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivangi","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Mone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Santulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"20","key":"3177_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of Cardiovascular\u2013kidney\u2013metabolic (CKM) Syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"1","key":"3177_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40842-026-00283-7","volume":"12","author":"G Santulli","year":"2026","unstructured":"Santulli G. Epidemiology of cardiovascular disease and diabetes in 2026: expanding prevalence, escalating costs, and the limits of contemporary prevention. Cardiovasc Diabetol Endocrinol Rep. 2026;12(1):15. https:\/\/doi.org\/10.1186\/s40842-026-00283-7.","journal-title":"Cardiovasc Diabetol Endocrinol Rep"},{"issue":"21","key":"3177_CR3","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1001\/jama.2023.22276","volume":"330","author":"H Larkin","year":"2023","unstructured":"Larkin H. Here\u2019s what to know about cardiovascular\u2013kidney\u2013metabolic syndrome, newly defined by the AHA. JAMA. 2023;330(21):2042\u20133.","journal-title":"JAMA"},{"issue":"1","key":"3177_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69819-0","volume":"14","author":"C Gao","year":"2024","unstructured":"Gao C, Gao S, Zhao R, Shen P, Zhu X, Yang Y, et al. Association between systemic immune-inflammation index and cardiovascular\u2013kidney\u2013metabolic syndrome. Sci Rep. 2024;14(1):19151.","journal-title":"Sci Rep"},{"issue":"6","key":"3177_CR5","first-page":"751","volume":"56","author":"S Wang","year":"2025","unstructured":"Wang S, Zeng J, Chen Y, Sun F, Ma H, Zhang L, et al. Association between systemic inflammation and worsening renal function in cardiovascular\u2013kidney\u2013metabolic syndrome. Am J Nephrol. 2025;56(6):751\u201361.","journal-title":"Am J Nephrol"},{"issue":"20","key":"3177_CR6","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular\u2013kidney\u2013metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"4","key":"3177_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1053\/j.ajkd.2024.09.016","volume":"85","author":"SM Rumrill","year":"2025","unstructured":"Rumrill SM, Shlipak MG. The new cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome: an opportunity for CKD detection and treatment in primary care. Am J Kidney Dis. 2025;85(4):399\u2013402.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"3177_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.nefroe.2024.11.011","volume":"44","author":"A Cases","year":"2024","unstructured":"Cases A, Broseta JJ, Marques M, Cigarran S, Julian JC, Alcazar R, et al. Cardiovascular\u2013kidney\u2013metabolic Syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the nephrology. Nefrolog\u00eda (English Edition). 2024;44(6):771\u201383.","journal-title":"Nefrolog\u00eda (English Edition)"},{"issue":"6 Pt 2","key":"3177_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101788","volume":"4","author":"I Shahid","year":"2025","unstructured":"Shahid I, Philip J, Avenatti E, Laddu D, Shapiro MD, Khera A, et al. Lifestyle interventions in Cardiovascular\u2013kidney\u2013metabolic Syndrome JACC: Advances expert panel. JACC Adv. 2025;4(6 Pt 2):101788.","journal-title":"JACC Adv"},{"key":"3177_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2024.07.014","volume":"127","author":"M Kanbay","year":"2024","unstructured":"Kanbay M, Guldan M, Ozbek L, Copur S, Covic AS, Covic A. Exploring the nexus: the place of kidney diseases within the Cardiovascular\u2013kidney\u2013metabolic Syndrome spectrum. Eur J Intern Med. 2024;127:1\u201314.","journal-title":"Eur J Intern Med"},{"issue":"6","key":"3177_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.103968","volume":"35","author":"A Gigante","year":"2025","unstructured":"Gigante A, Pellicano C, Martellucci O, Villa A, Duca E, Alunni-Fegatelli D, et al. Metabolic syndrome and cardiovascular\u2013kidney\u2013metabolic health: evaluation of predictive risk factor for mortality in systemic sclerosis. Nutr Metab Cardiovasc Dis. 2025;35(6):103968.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"3177_CR12","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.cmet.2023.10.015","volume":"35","author":"SE Claudel","year":"2023","unstructured":"Claudel SE, Verma A. Cardiovascular\u2013kidney\u2013metabolic Syndrome: A step toward multidisciplinary and inclusive care. Cell Metab. 2023;35(12):2104\u20136.","journal-title":"Cell Metab"},{"issue":"1","key":"3177_CR13","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00499.2025","volume":"330","author":"S Gunnarsson","year":"2026","unstructured":"Gunnarsson S, Vito O, Unwin RJ. Cardiovascular\u2013kidney\u2013metabolic Syndrome: prevalence, risks, disease trajectories, and early-stage management. Am J Physiol Cell Physiol. 2026;330(1):C1\u20138.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"3177_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jacasi.2024.10.016","volume":"5","author":"Q Huang","year":"2025","unstructured":"Huang Q, Li Y, Zhou X, Zou X, Ji L. Prevalence of the Cardiovascular\u2013kidney\u2013metabolic Syndrome in 3 Chinese cohorts. JACC Asia. 2025;5(1):116\u20138.","journal-title":"JACC Asia"},{"key":"3177_CR15","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2025005","volume":"47","author":"SB Hong","year":"2025","unstructured":"Hong SB, Kim JE, Han SS, Shearer JJ, Joo J, Choi JY, et al. Prevalence of Cardiovascular\u2013kidney\u2013metabolic Syndrome in Korea: Korea National Health and Nutrition Examination Survey 2011\u20132021. Epidemiol Health. 2025;47:e2025005.","journal-title":"Epidemiol Health"},{"issue":"18","key":"3177_CR16","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.jacc.2024.03.368","volume":"83","author":"AMK Minhas","year":"2024","unstructured":"Minhas AMK, Mathew RO, Sperling LS, Nambi V, Virani SS, Navaneethan SD, et al. Prevalence of the Cardiovascular\u2013kidney\u2013metabolic Syndrome in the United States. J Am Coll Cardiol. 2024;83(18):1824\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"3177_CR17","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular\u2013kidney\u2013metabolic Syndrome stages in US adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360.","journal-title":"JAMA"},{"issue":"11","key":"3177_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.45309","volume":"7","author":"R Zhu","year":"2024","unstructured":"Zhu R, Wang R, He J, Wang L, Chen H, Niu X, et al. Prevalence of Cardiovascular\u2013kidney\u2013metabolic Syndrome stages by social determinants of health. JAMA Netw Open. 2024;7(11):e2445309.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3177_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1159\/000546618","volume":"15","author":"L Lei","year":"2025","unstructured":"Lei L, Li J, Ding W, Wang W, Yu Y, Pu B, et al. Associations of Cardiovascular\u2013kidney\u2013metabolic Syndrome with premature mortality and life expectancies in US adults: A cohort study. Cardiorenal Med. 2025;15(1):484\u201395.","journal-title":"Cardiorenal Med"},{"issue":"8","key":"3177_CR20","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1681\/ASN.0000000658","volume":"36","author":"Z Xie","year":"2025","unstructured":"Xie Z, Yu C, Cui Q, Zhao X, Zhuang J, Chen S, et al. Global burden of the key components of Cardiovascular\u2013kidney\u2013metabolic Syndrome. J Am Soc Nephrol. 2025;36(8):1572\u201384.","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"3177_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.034996","volume":"13","author":"J Li","year":"2024","unstructured":"Li J, Lei L, Wang W, Ding W, Yu Y, Pu B, et al. Social risk profile and Cardiovascular\u2013kidney\u2013metabolic Syndrome in US adults. J Am Heart Assoc. 2024;13(16):e034996.","journal-title":"J Am Heart Assoc"},{"key":"3177_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2025.108360","volume":"202","author":"Y Wang","year":"2026","unstructured":"Wang Y, Dong T, Wang B, Zhang P. The association between Life\u2019s Essential 8 health behavior component score and all-cause and cardiovascular mortality among U.S. adults with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133. Prev Med. 2026;202:108360.","journal-title":"Prev Med"},{"issue":"5","key":"3177_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41581-025-00957-y","volume":"21","author":"EF Carney","year":"2025","unstructured":"Carney EF. Cardiovascular mortality increases with stage of Cardiovascular\u2013kidney\u2013metabolic Syndrome. Nat Rev Nephrol. 2025;21(5):283.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"3177_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-01195-w","volume":"5","author":"Q Chen","year":"2025","unstructured":"Chen Q, Zhu Y, Gao J, Ni W, Liu S, Rui F, et al. Cardiovascular\u2013kidney\u2013metabolic (CKM) Syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). Commun Med. 2025;5(1):492.","journal-title":"Commun Med"},{"issue":"7","key":"3177_CR25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1681\/ASN.0000000637","volume":"36","author":"SE Claudel","year":"2025","unstructured":"Claudel SE, Schmidt IM, Waikar SS, Verma A. Cumulative incidence of mortality associated with Cardiovascular\u2013kidney\u2013metabolic (CKM) Syndrome. J Am Soc Nephrol. 2025;36(7):1343\u201351.","journal-title":"J Am Soc Nephrol"},{"key":"3177_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111926","volume":"218","author":"V Trimarco","year":"2024","unstructured":"Trimarco V, Izzo R, Pacella D, Manzi VM, Trama U, Lembo M, et al. Increased prevalence of Cardiovascular\u2013kidney\u2013metabolic Syndrome during COVID-19: a propensity score-matched study. Diabetes Res Clin Pract. 2024;218:111926.","journal-title":"Diabetes Res Clin Pract"},{"key":"3177_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-025-01044-y","author":"Y Drexler","year":"2025","unstructured":"Drexler Y, Fornoni A. Advances in risk prediction and treatment strategies for CKM syndrome. Nat Rev Nephrol. 2025. https:\/\/doi.org\/10.1038\/s41581-025-01044-y.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"3177_CR28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3904\/kjim.2024.273","volume":"39","author":"YY Hyun","year":"2024","unstructured":"Hyun YY. Obesity and chronic kidney disease, an important piece in the puzzle of Cardiovascular-Kidney- Metabolic Syndrome. Korean J Intern Med. 2024;39(5):700\u20131.","journal-title":"Korean J Intern Med"},{"key":"3177_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156081","volume":"163","author":"ZA Kipp","year":"2025","unstructured":"Kipp ZA, Badmus OO, Stec DE, Hall B, Hinds TD Jr. Bilirubin bioconversion to urobilin in the gut-liver-kidney axis: a biomarker for insulin resistance in the Cardiovascular\u2013kidney\u2013metabolic (CKM) Syndrome. Metabolism. 2025;163:156081.","journal-title":"Metabolism"},{"issue":"11","key":"3177_CR30","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","volume":"126","author":"RH Ritchie","year":"2020","unstructured":"Ritchie RH, Abel ED. Basic mechanisms of diabetic heart disease. Circ Res. 2020;126(11):1501\u201325.","journal-title":"Circ Res"},{"key":"3177_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154910","volume":"125","author":"SS Jankauskas","year":"2021","unstructured":"Jankauskas SS, Kansakar U, Varzideh F, Wilson S, Mone P, Lombardi A, et al. Heart failure in diabetes. Metabolism. 2021;125:154910.","journal-title":"Metabolism"},{"key":"3177_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03103-5","author":"M Packer","year":"2026","unstructured":"Packer M. Causal demonstration of adiposity-induced adipose-specific signaling derangements in the pathogenesis of the clinical features of the cardiovascular-kidney metabolic syndrome. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03103-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3177_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01993-1","volume":"17","author":"R Liu","year":"2025","unstructured":"Liu R, Yang G, Liu Y, Li J, Xu B, Ye G, et al. Which insulin resistance indices best predict future frailty progression in a Cardiovascular\u2013kidney\u2013metabolic Syndrome stage 0-3 population: a national prospective cohort and machine learning study. Diabetol Metab Syndr. 2025;17(1):425.","journal-title":"Diabetol Metab Syndr"},{"key":"3177_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.104361","volume":"36","author":"J Wang","year":"2025","unstructured":"Wang J, Du B. The prognostic significance of metabolic score for insulin resistance in evaluating all-cause and cardiovascular mortality risk among individuals across stages 1\u20134 of cardiovascular\u2013kidney\u2013metabolic syndrome: a nationwide prospective cohort study. Nutr Metab Cardiovasc Dis. 2025;36:104361.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"3177_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02932-0","volume":"24","author":"H Wu","year":"2025","unstructured":"Wu H, Zhou Y, Lai X, Ma B, Ding L, Zhu X, et al. Association between metabolic score for insulin resistance and future stroke risk in patients with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):379.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3177_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02860-z","volume":"24","author":"H Zhang","year":"2025","unstructured":"Zhang H, Huang S, Fang Y, Zhang H, Yang W, Yu M. Insulin resistance assessed by estimated glucose disposal rate predicts cardiovascular disease in stages 0\u20133 of cardiovascular\u2013kidney\u2013metabolic syndrome: a UK biobank cohort study. Cardiovasc Diabetol. 2025;24(1):360.","journal-title":"Cardiovasc Diabetol"},{"key":"3177_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112327","volume":"226","author":"M Wang","year":"2025","unstructured":"Wang M, Lin W, Liu H, Qian ZM, Chen J, Rao M, et al. Associations between insulin resistance indices and cardiovascular disease in older adults with cardiovascular\u2013kidney\u2013metabolic syndrome stage 0\u20133: the GOLD-Health cohort. Diabetes Res Clin Pract. 2025;226:112327.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"3177_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12933-025-02729-1","volume":"24","author":"B Dong","year":"2025","unstructured":"Dong B, Chen Y, Yang X, Chen Z, Zhang H, Gao Y, et al. Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133 and the development of a machine learning prediction model: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):163.","journal-title":"Cardiovasc Diabetol"},{"key":"3177_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-02062-3","author":"L Huang","year":"2025","unstructured":"Huang L, Lin B, Mu Y, Ren Y, Li Q, Li Y, et al. Associations of inflammation-related hematological profile with the early-stages of cardiovascular\u2013kidney\u2013metabolic syndrome and the mediating role of body composition: evidence from the China National Health Survey. Diabetol Metab Syndr. 2025. https:\/\/doi.org\/10.1186\/s13098-025-02062-3.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3177_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12026-025-09707-5","volume":"73","author":"Y Qu","year":"2025","unstructured":"Qu Y, Wang L, Liu L, Sun Y. Myeloid inflammation thresholds stratify mortality risk in early-stage cardiovascular\u2013kidney\u2013metabolic syndrome: MLR-driven findings from NHANES. Immunol Res. 2025;73(1):174.","journal-title":"Immunol Res"},{"key":"3177_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-25894-0","author":"S Zhang","year":"2025","unstructured":"Zhang S, Tang H, Pan L, Zhou M. Association of metal and metalloid exposure with cardiovascular\u2013kidney\u2013metabolic syndrome: mediation by inflammation, oxidative stress, and aging. BMC Public Health. 2025. https:\/\/doi.org\/10.1186\/s12889-025-25894-0.","journal-title":"BMC Public Health"},{"issue":"1","key":"3177_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05109-5","volume":"25","author":"J Zhang","year":"2025","unstructured":"Zhang J, Tu D. Association between systemic inflammation response index and advanced stages in U.S. cardiovascular\u2013kidney\u2013metabolic syndrome patients: a cross-sectional study using NHANES 2015-2020 data. BMC Cardiovasc Disord. 2025;25(1):815.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"3177_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-24690-5","volume":"15","author":"X Xu","year":"2025","unstructured":"Xu X, Tang L, Kang Y, Liang J, Geng W, Wang Y. Association of air pollutions and systemic inflammation with early cardiovascular\u2013kidney\u2013metabolic syndrome among middle-aged and elderly adults: a cross-sectional study from CHARLS. Sci Rep. 2025;15(1):39377.","journal-title":"Sci Rep"},{"key":"3177_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112989","volume":"230","author":"C Zhang","year":"2025","unstructured":"Zhang C, Chen Y, Wang T, Peng W, Ning M, Liu Y. Inflammation and abnormal glucose-lipid metabolism are critical for population stratification toward progressive frailty in cardiovascular\u2013kidney\u2013metabolic syndrome. Diabetes Res Clin Pract. 2025;230:112989.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"3177_CR45","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1007\/s11010-025-05379-9","volume":"480","author":"Z Xu","year":"2025","unstructured":"Xu Z, Yang S, Tan Y, Zhang Q, Wang H, Tao J, et al. Inflammation in cardiovascular\u2013kidney\u2013metabolic syndrome: key roles and underlying mechanisms-a comprehensive review. Mol Cell Biochem. 2025;480(12):6039\u201375.","journal-title":"Mol Cell Biochem"},{"key":"3177_CR46","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.2147\/DMSO.S532423","volume":"18","author":"Y Xie","year":"2025","unstructured":"Xie Y, Shen K, Xu J, Li L, Chen L. Associations between fatigue and cardiovascular\u2013kidney\u2013metabolic syndrome and the mediating role of inflammation. Diabetes Metab Syndr Obes. 2025;18:2851\u201362.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"3177_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02929-1","volume":"30","author":"Y Huang","year":"2025","unstructured":"Huang Y, Yin X, Li Z. Impact of systemic immune inflammation index and systemic inflammation response index on all-cause and cardiovascular mortality in cardiovascular\u2013kidney\u2013metabolic syndrome. Eur J Med Res. 2025;30(1):645.","journal-title":"Eur J Med Res"},{"issue":"1","key":"3177_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01805-6","volume":"17","author":"P Li","year":"2025","unstructured":"Li P, Zhang H, Ma J, Wang J, Lv S, Zhao X, et al. Cardiovascular\u2013kidney\u2013metabolic Syndrome, systemic inflammation, and incident dementia: evidence from 400,740 UK Biobank participants. Diabetol Metab Syndr. 2025;17(1):253.","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"3177_CR49","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s13300-025-01743-6","volume":"16","author":"R Ghafoury","year":"2025","unstructured":"Ghafoury R, Malek M, Ismail-Beigi F, Khamseh ME. Role of residual inflammation as a risk factor across Cardiovascular\u2013kidney\u2013metabolic (CKM) Syndrome: unpacking the burden in people with Type 2 Diabetes. Diabetes Ther. 2025;16(7):1341\u201365.","journal-title":"Diabetes Ther"},{"issue":"1","key":"3177_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02692-x","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Lian W, Wu L, Huang A, Zhang D, Liu B, et al. Joint association of estimated glucose disposal rate and systemic inflammation response index with mortality in Cardiovascular\u2013kidney\u2013metabolic Syndrome stage 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):147.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3177_CR51","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1186\/s12889-025-23157-6","volume":"25","author":"H Wang","year":"2025","unstructured":"Wang H, Zhang Y, Sun M, Chen Z. Nonlinear association of physical activity with early Cardiovascular\u2013kidney\u2013metabolic Syndrome risk: a comprehensive analysis of NHANES data from 2007 to 2018. BMC Public Health. 2025;25(1):1965.","journal-title":"BMC Public Health"},{"issue":"1","key":"3177_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-025-00974-5","volume":"22","author":"L Duan","year":"2025","unstructured":"Duan L, Yang H, Chen Z, Zhao J, Yang J, Cai D. Dietary antioxidants and mortality in early-stage CKM Syndrome: insights from NHANES. Nutr Metab (Lond). 2025;22(1):77.","journal-title":"Nutr Metab (Lond)"},{"key":"3177_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063298","author":"YL Tain","year":"2024","unstructured":"Tain YL, Hsu CN. The renin\u2013angiotensin system and cardiovascular\u2013kidney\u2013metabolic syndrome: focus on early-life programming. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25063298.","journal-title":"Int J Mol Sci"},{"key":"3177_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/mi\/6691516","volume":"2025","author":"J Song","year":"2025","unstructured":"Song J, Xu Z, Yu H, Li A, Liu Y, Jin M. Association of three composite inflammatory and lipid metabolism indicators with Cardiovascular\u2013kidney\u2013metabolic Syndrome: a cross-sectional study based on NHANES 1999-2020. Mediators Inflamm. 2025;2025:6691516.","journal-title":"Mediators Inflamm"},{"issue":"12","key":"3177_CR55","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41371-025-01078-6","volume":"39","author":"L Ghazi","year":"2025","unstructured":"Ghazi L, Dubal M, Bertoni A, Carson A, Young BA, Lewis CE, et al. Role of hypertension in the cardiovascular\u2013kidney\u2013metabolic syndrome among black adults: the Jackson Heart Study. J Hum Hypertens. 2025;39(12):822\u201330.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"3177_CR56","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1428","volume":"20","author":"A Rosende","year":"2025","unstructured":"Rosende A, Romero C, DiPette DJ, Brettler J, Van der Stuyft P, Satheesh G, et al. Candidate interventions for integrating hypertension and cardiovascular\u2013kidney\u2013metabolic care in primary health settings: HEARTS 2.0 Phase 1. Glob Heart. 2025;20(1):45.","journal-title":"Glob Heart"},{"issue":"1\u20132","key":"3177_CR57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000528783","volume":"54","author":"CW Mende","year":"2023","unstructured":"Mende CW, Samarakoon R, Higgins PJ. Mineralocorticoid receptor-associated mechanisms in diabetic kidney disease and clinical significance of mineralocorticoid receptor antagonists. Am J Nephrol. 2023;54(1\u20132):50\u201361.","journal-title":"Am J Nephrol"},{"key":"3177_CR58","volume":"61","author":"K Matsumoto","year":"2026","unstructured":"Matsumoto K, Otsuka K, Kagawa S, Yamaura H, Miura T, Sugioka K, et al. Integration of BNP and blood glucose for identifying coronary flow reserve impairment: a Cardiovascular\u2013kidney\u2013metabolic perspective. Am Heart J Plus. 2026;61:100671.","journal-title":"Am Heart J Plus"},{"key":"3177_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.118585","volume":"397","author":"N Li","year":"2024","unstructured":"Li N, Li Y, Cui L, Shu R, Song H, Wang J, et al. Association between different stages of Cardiovascular\u2013kidney\u2013metabolic Syndrome and the risk of all-cause mortality. Atherosclerosis. 2024;397:118585.","journal-title":"Atherosclerosis"},{"key":"3177_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1665836","volume":"16","author":"S Zeng","year":"2025","unstructured":"Zeng S, Cui H, Liao W, Qiu S, Wang Z, Wu Z, et al. Association between vascular aging and cardiovascular\u2013kidney\u2013metabolic syndrome. Front Endocrinol (Lausanne). 2025;16:1665836.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3177_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102277","volume":"4","author":"Y Fukuda","year":"2025","unstructured":"Fukuda Y, Ejiri K. Vascular aging and cardiovascular\u2013kidney\u2013metabolic syndrome: disease mechanisms and risk evaluation for cardiovascular disease. JACC Adv. 2025;4:102277.","journal-title":"JACC Adv"},{"key":"3177_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102242","volume":"4","author":"J Shi","year":"2025","unstructured":"Shi J, Ye X, Yu S, Zhao Y, Xiong J, Ji H, et al. Vascular Aging, Cardiovascular\u2013kidney\u2013metabolic Syndrome, and Cardiovascular Risk: The Northern Shanghai Study. JACC Adv. 2025;4:102242.","journal-title":"JACC Adv"},{"issue":"2","key":"3177_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jacc.2024.05.005","volume":"84","author":"JW Ostrominski","year":"2024","unstructured":"Ostrominski JW, Claggett BL, Miao ZM, Mc Causland FR, Anand IS, Desai AS, et al. Cardiovascular\u2013kidney\u2013metabolic overlap in heart failure with mildly reduced or preserved ejection fraction: a trial-level analysis. J Am Coll Cardiol. 2024;84(2):223\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3177_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2025.102755","volume":"14","author":"A Shah","year":"2026","unstructured":"Shah A, McDermott J, Rao VN, Gupta M, Barnes SG, Green CL, et al. In-hospital virtual consultation to implement guideline-directed medical therapy for cardiovascular\u2013kidney\u2013metabolic disease: the IMPLEMENT-CRM Randomized Trial. JACC Heart Fail. 2026;14(3):102755.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"3177_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02662-3","volume":"24","author":"J Hong","year":"2025","unstructured":"Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X. Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):98.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3177_CR66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13098-025-01671-2","volume":"17","author":"FS Guo","year":"2025","unstructured":"Guo FS, Dou JH, Wang JX, Guo C, Wu RY, Sun XL, et al. Association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in population with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20134: evidence from a large cohort study. Diabetol Metab Syndr. 2025;17(1):109.","journal-title":"Diabetol Metab Syndr"},{"key":"3177_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1548851","volume":"12","author":"Y Duan","year":"2025","unstructured":"Duan Y, Yang K, Zhang T, Guo X, Yin Q, Liu H. Association between non-highdensity lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiovascular\u2013kidney\u2013metabolic syndrome: evidence from NHANES 2001-2018. Front Nutr. 2025;12:1548851.","journal-title":"Front Nutr"},{"key":"3177_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1613721","volume":"12","author":"J Liu","year":"2025","unstructured":"Liu J, Song Y, Luo R, Wang S, Pan P, Han L. Association between urinary heavy metals and cardiovascular\u2013kidney\u2013metabolic syndrome: mediating roles of TyG, WWI, and eGFR. Front Nutr. 2025;12:1613721.","journal-title":"Front Nutr"},{"issue":"14","key":"3177_CR69","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.039983","volume":"14","author":"Z Liu","year":"2025","unstructured":"Liu Z, Zhou D, Tang Y, Huo G. Association of Atherogenic Index of Plasma with stroke risk in a population with Cardiovascular\u2013kidney\u2013metabolic Syndrome stages 0 to 3: the first evidence from the China Health and Retirement Longitudinal Study. J Am Heart Assoc. 2025;14(14):e039983.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3177_CR70","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12872-025-04918-y","volume":"25","author":"DG Mo","year":"2025","unstructured":"Mo DG, Liu T, Bai JX, Liu M, Han QF, Yao HC. Association between the cardiometabolic index and cardiovascular disease risk in patients with cardiovascular\u2013kidney\u2013metabolic syndrome: a cohort study. BMC Cardiovasc Disord. 2025;25(1):451.","journal-title":"BMC Cardiovasc Disord"},{"key":"3177_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1622590","volume":"12","author":"G Wang","year":"2025","unstructured":"Wang G, Li G, Wang P, Zang M, Pu J. Association between albumin to globulin ratio and all-cause and cardiovascular mortality among individuals with cardiovascular\u2013kidney\u2013metabolic syndrome: results from NHANES 2003 to 2018. Front Nutr. 2025;12:1622590.","journal-title":"Front Nutr"},{"issue":"1","key":"3177_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02784-8","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y, et al. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0-3: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):254.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3177_CR73","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-025-02732-6","volume":"24","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li W, Zhou H, Zeng H, Jiang J, Wang Q, et al. Association between atherogenic index of plasma and new-onset stroke in a population with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133: insights from CHARLS. Cardiovasc Diabetol. 2025;24(1):168.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3177_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02754-0","volume":"24","author":"L Lu","year":"2025","unstructured":"Lu L, Chen Y, Liu B, Li X, Wang J, Nie Z, et al. Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular\u2013kidney\u2013metabolic syndrome stage 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):202.","journal-title":"Cardiovasc Diabetol"},{"key":"3177_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1552219","volume":"16","author":"F Han","year":"2025","unstructured":"Han F, Guo H, Zhang H, Zheng Y. hs-CRP\/HDL-C can predict the risk of all cause mortality in cardiovascular\u2013kidney\u2013metabolic syndrome stage 1-4 patients. Front Endocrinol (Lausanne). 2025;16:1552219.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3177_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05019-6","volume":"25","author":"X Ma","year":"2025","unstructured":"Ma X, Tang X, Chen S, Wu T, Zuo P, Wu F, et al. The advanced lung cancer inflammation index and mortality in patients with cardiovascular-kidney metabolic syndrome: insights from NHANES. BMC Cardiovasc Disord. 2025;25(1):568.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"3177_CR77","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2024.10.007","volume":"37","author":"S Li","year":"2025","unstructured":"Li S, Liu H, Hu H, Ha E, Prasad P, Jenkins BC, et al. Human genetics identify convergent signals in mitochondrial LACTB-mediated lipid metabolism in cardiovascular\u2013kidney\u2013metabolic syndrome. Cell Metab. 2025;37(1):154-168 e457.","journal-title":"Cell Metab"},{"key":"3177_CR78","doi-asserted-by":"crossref","unstructured":"Zhou XD, Chen QF, Fan QY, Kim SU, Yip TC, Petta S, Nakajima A, Tsochatzis E, Boursier J, Bugianesi E et al. Cardiovascular\u2013kidney\u2013metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD. Hepatology 2025.","DOI":"10.1097\/HEP.0000000000001645"},{"key":"3177_CR79","doi-asserted-by":"publisher","first-page":"C409","DOI":"10.1152\/ajpcell.00769.2025","volume":"330","author":"F Genovese","year":"2025","unstructured":"Genovese F, Karsdal M, Devos H, Bager C, Nunez J, Bayes-Genis A. Endotrophin as a biomarker and mediator in cardiovascular\u2013kidney\u2013metabolic syndrome: current insights and remaining questions. Am J Physiol Cell Physiol. 2025;330:C409.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"3177_CR80","doi-asserted-by":"publisher","first-page":"e1573403X133267","DOI":"10.2174\/011573403X332671241121063641","volume":"21","author":"K Tiwari","year":"2025","unstructured":"Tiwari K, Saravanan A, Anil A, Tiwari VK, Shamim MA, Singh S, et al. Molecular and functional significance of growth differentiation factor-15: a review on cardiovascular\u2013kidney\u2013metabolic biomarker. Curr Cardiol Rev. 2025;21(3):e1573403X1332671.","journal-title":"Curr Cardiol Rev"},{"key":"3177_CR81","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12920-026-02315-8","volume":"19","author":"HC Donker","year":"2026","unstructured":"Donker HC, Bisht V, Dwivedi OP, Mueller S, Neijzen D, Ding Z, et al. Cardiovascular\u2013kidney\u2013metabolic syndrome: candidate subtypes and genetic risk factors. BMC Med Genomics. 2026;19:47.","journal-title":"BMC Med Genomics"},{"issue":"24","key":"3177_CR82","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","volume":"148","author":"SS Khan","year":"2023","unstructured":"Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular\u2013kidney\u2013metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148(24):1982\u20132004.","journal-title":"Circulation"},{"issue":"1","key":"3177_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03560-w","volume":"30","author":"Z Zhuang","year":"2025","unstructured":"Zhuang Z, Liu X, Lu H, Wu Q, Chen Y, Ni Q. Neutrophil percentage to albumin ratio and advanced cardiovascular\u2013kidney\u2013metabolic syndrome in diabetes: a machine learning approach. Eur J Med Res. 2025;30(1):1248.","journal-title":"Eur J Med Res"},{"key":"3177_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1659340","volume":"16","author":"L Gong","year":"2025","unstructured":"Gong L, Yang R, Cui H, Zhao J, Liu J, Lv X, et al. The impact of short-term comprehensive treatment on cardiovascular\u2013kidney\u2013metabolic syndrome and its components in patients with type 2 diabetes. Front Endocrinol (Lausanne). 2025;16:1659340.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3177_CR85","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12933-026-03084-5","volume":"25","author":"SS Han","year":"2026","unstructured":"Han SS, Liu Q, Zeng ZM, Li Y, Li PW, Cheng FX, Zhong P, Li JB. Association of various insulin resistance surrogate indices with aging acceleration and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: insights from CHARLS 2011\u20132020 data. Cardiovasc Diabetol. 2026;25(1):77. https:\/\/doi.org\/10.1186\/s12933-026-03084-5.","journal-title":"Cardiovasc Diabetol"},{"key":"3177_CR86","doi-asserted-by":"publisher","unstructured":"Jin X, Feng Y, Liu C, Cheng T, Jin Y, Shao Z, Bian Y, Wu H, Li J, Liu Y, Wei L, Qi Z, Qi X. Association between triglyceride-glucose index and related indicators with heart failure-related mortality in individuals with early-stage cardiovascular-kidney-metabolic syndrome. Cardiovasc Diabetol. 2026 (in press). https:\/\/doi.org\/10.1186\/s12933-026-03149-5.","DOI":"10.1186\/s12933-026-03149-5"},{"issue":"10","key":"3177_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2025.109146","volume":"39","author":"K Nishizawa","year":"2025","unstructured":"Nishizawa K, Tanaka M, Sato T, Gohda T, Kamei N, Murakoshi M, et al. The health stage of cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome is useful for predicting all-cause mortality in patients with type 2 diabetes: a cohort study in a period prior to the standard use of recent pharmacotherapy. J Diabetes Complications. 2025;39(10):109146.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"3177_CR88","doi-asserted-by":"publisher","first-page":"bvae208","DOI":"10.1210\/jendso\/bvae208","volume":"9","author":"KE Belay","year":"2024","unstructured":"Belay KE, Feleke Y, Alemneh TA, Haile AM, Abebe DG. Social determinants of health for cardiovascular\u2013kidney\u2013metabolic syndrome among patients with diabetes. J Endocr Soc. 2024;9(1):bvae208.","journal-title":"J Endocr Soc"},{"issue":"6","key":"3177_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3835","volume":"40","author":"W Liu","year":"2024","unstructured":"Liu W, Wang W, Sun F, Jiang N, Yuan L, Bu X, et al. Machine learning-assisted analysis of sublingual microcirculatory dysfunction for early cardiovascular risk evaluation and cardiovascular\u2013kidney\u2013metabolic syndrome stage in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2024;40(6):e3835.","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"3177_CR90","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41581-024-00812-6","volume":"20","author":"SE Quaggin","year":"2024","unstructured":"Quaggin SE, Magod B. A united vision for cardiovascular\u2013kidney\u2013metabolic health. Nat Rev Nephrol. 2024;20(5):273\u20134.","journal-title":"Nat Rev Nephrol"},{"key":"3177_CR91","first-page":"10","volume":"360","author":"K de Wolski","year":"2025","unstructured":"de Wolski K, Prince DK, Mariuma D, Arora N, Velu TN, Gupta A, et al. Experience and outcomes of a dedicated cardio-nephrology service: a step towards integrated cardiovascular\u2013kidney\u2013metabolic syndrome care. Kidney. 2025;360:10.","journal-title":"Kidney"},{"key":"3177_CR92","doi-asserted-by":"crossref","unstructured":"Su G, Liao B, Guo Y, Yang C, Staplin N. Trends in nephrology: cardiovascular kidney-metabolic syndrome. Nephrol Dial Transplant 2025.","DOI":"10.1093\/ndt\/gfaf250"},{"issue":"5","key":"3177_CR93","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/ASN.0000000000000323","volume":"35","author":"N Bansal","year":"2024","unstructured":"Bansal N, Weiner D, Sarnak M. Cardiovascular\u2013kidney\u2013metabolic Health Syndrome: what does the American Heart Association framework mean for nephrology? J Am Soc Nephrol. 2024;35(5):649\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"3177_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103596","volume":"90","author":"M Wang","year":"2025","unstructured":"Wang M, Qiao Y, Lin R, Yu Y, Zhao M, Standl M, et al. Association between cardiovascular\u2013kidney\u2013metabolic syndrome, lifestyle, and all-cause and cause-specific mortality: a prospective cohort study. EClinicalMedicine. 2025;90:103596.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"3177_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03339-z","volume":"30","author":"P Li","year":"2025","unstructured":"Li P, Sun X, Sun Y, Shang H, Tu D. Correlation between overall lifestyle score and advanced stages among patients with cardiovascular\u2013kidney\u2013metabolic syndrome: NHANES 2011-2020. Eur J Med Res. 2025;30(1):1063.","journal-title":"Eur J Med Res"},{"issue":"2","key":"3177_CR96","doi-asserted-by":"publisher","first-page":"H432","DOI":"10.1152\/ajpheart.00353.2025","volume":"329","author":"Z Papadakis","year":"2025","unstructured":"Papadakis Z. NIH cuts: a costly retreat-defunding precision lifestyle medicine amid the cardiovascular\u2013kidney\u2013metabolic crisis. Am J Physiol Heart Circ Physiol. 2025;329(2):H432\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"16","key":"3177_CR97","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/eurjpc\/zwaf169","volume":"32","author":"Z Papadakis","year":"2025","unstructured":"Papadakis Z. Advancing the translational integration of lifestyle medicine in cardiovascular\u2013kidney\u2013metabolic syndrome. Eur J Prev Cardiol. 2025;32(16):1676\u20138.","journal-title":"Eur J Prev Cardiol"},{"key":"3177_CR98","doi-asserted-by":"crossref","unstructured":"Gregg LP, Bozkurt B, Navaneethan SD. Risk assessment in cardiovascular\u2013kidney\u2013metabolic syndrome: an opportunity to individualize evidence-based therapy in CKD. Clin J Am Soc Nephrol 2025.","DOI":"10.2215\/CJN.0000000973"},{"issue":"7-8","key":"3177_CR99","doi-asserted-by":"publisher","first-page":"760","DOI":"10.33963\/v.phj.101062","volume":"82","author":"K Batko","year":"2024","unstructured":"Batko K, Saczek A, Banaszkiewicz M, Malyszko J, Koc-Zorawska E, Zorawski M, et al. Comprehensive assessment of cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome: novel tools for assessment of cardiovascular risk and kidney outcomes in long-term kidney transplant patients. Kardiol Pol. 2024;82(7\u20138):760\u201370.","journal-title":"Kardiol Pol"},{"key":"3177_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1660319","volume":"16","author":"Y Zou","year":"2025","unstructured":"Zou Y, Zhang Y, Sun X, Zhao W, Zhang G. Osteoarthritis as a clinical marker of cardiovascular\u2013kidney\u2013metabolic multimorbidity: a population-based cohort study in China. Front Endocrinol (Lausanne). 2025;16:1660319.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3177_CR101","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12889-024-21131-2","volume":"25","author":"Y Cao","year":"2025","unstructured":"Cao Y, Wang W, Xie S, Xu Y, Lin Z. Joint association of the inflammatory marker and cardiovascular\u2013kidney\u2013metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study. BMC Public Health. 2025;25(1):10.","journal-title":"BMC Public Health"},{"issue":"2","key":"3177_CR102","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2215\/CJN.04830610","volume":"6","author":"N Satoh-Asahara","year":"2011","unstructured":"Satoh-Asahara N, Suganami T, Majima T, Kotani K, Kato Y, Araki R, et al. Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome. Clin J Am Soc Nephrol. 2011;6(2):265\u201373.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"3177_CR103","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/joim.70066","volume":"299","author":"HJ Kramer","year":"2026","unstructured":"Kramer HJ, Bakris GL. The urinary albumin-to-creatinine ratio can direct personalized prevention and treatment for cardiovascular and chronic kidney disease. J Intern Med. 2026;299(4):444\u201366.","journal-title":"J Intern Med"},{"issue":"3","key":"3177_CR104","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.046271","volume":"15","author":"J Sartini","year":"2026","unstructured":"Sartini J, Rooney MR, Schrack JA, McEvoy JW, Ndumele CE, Zeger S, et al. Light physical activity and all-cause mortality in US adults across Cardiovascular\u2013kidney\u2013metabolic Syndrome stages. J Am Heart Assoc. 2026;15(3):e046271.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"3177_CR105","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.0000000859","volume":"21","author":"J Uribarri","year":"2026","unstructured":"Uribarri J, Tuttle KR. Dietary advanced glycation end products and cardiovascular\u2013kidney\u2013metabolic complications. Clin J Am Soc Nephrol. 2026;21(2):332\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"3177_CR106","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1007\/s11695-025-07939-w","volume":"35","author":"YM Lin","year":"2025","unstructured":"Lin YM, Kao CL, Hung KC, Yu T, Liu MY, Lai CC, et al. Impact of bariatric metabolic surgery on cardiovascular, kidney, and mortality outcomes among adults with obesity and chronic kidney disease across different time frames. Obes Surg. 2025;35(8):2877\u201386.","journal-title":"Obes Surg"},{"issue":"6","key":"3177_CR107","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038191","volume":"14","author":"L Wang","year":"2025","unstructured":"Wang L, Zhang X, Chen Y, Flynn CR, English WJ, Samuels JM, et al. Reduced Risk of Cardiovascular Diseases After Bariatric Surgery Based on the New Predicting Risk of Cardiovascular Disease EVENTs Equations. J Am Heart Assoc. 2025;14(6):e038191.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3177_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04645-8","volume":"27","author":"S Lin","year":"2025","unstructured":"Lin S, Liu R, Huang W, Liu L, Zhang B, Xu J, et al. Effect of statin therapy on renal and lipid outcomes in CKM syndrome stage 2: a meta-analysis of randomized controlled trials. BMC Nephrol. 2025;27(1):36.","journal-title":"BMC Nephrol"},{"issue":"3","key":"3177_CR109","doi-asserted-by":"publisher","first-page":"102727","DOI":"10.1016\/j.jchf.2025.102727","volume":"14","author":"AS Bhatt","year":"2026","unstructured":"Bhatt AS, De Oliveira-Gomes D, Fiuzat M, Vaduganathan M, Hamo CE, Stockbridge N, et al. Assessing medical therapy optimization in cardiovascular\u2013kidney\u2013metabolic clinical trials: an initiative from the Heart Failure Collaboratory. JACC Heart Fail. 2026;14(3):102727.","journal-title":"JACC Heart Fail"},{"key":"3177_CR110","volume":"57","author":"L Luo","year":"2025","unstructured":"Luo L, Luo X, He Z. Serum uric acid, renal status, cardiovascular\u2013kidney\u2013metabolic syndrome and drug therapy, a wide-angled Mendelian randomization analysis. Am Heart J Plus. 2025;57:100587.","journal-title":"Am Heart J Plus"},{"issue":"8","key":"3177_CR111","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/JCMA.0000000000001263","volume":"88","author":"CE Chiang","year":"2025","unstructured":"Chiang CE, Wang KL, Cheng HM, Chao TF, Sung SH. Incretin-based therapy: an update focusing on the major revolution in cardiovascular\u2013kidney\u2013metabolic health. J Chin Med Assoc. 2025;88(8):585\u201393.","journal-title":"J Chin Med Assoc"},{"issue":"20","key":"3177_CR112","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMe2503600","volume":"392","author":"F Zannad","year":"2025","unstructured":"Zannad F. Seeking multiorgan benefits with cardiovascular\u2013kidney\u2013metabolic drug therapy. N Engl J Med. 2025;392(20):2061\u20132.","journal-title":"N Engl J Med"},{"issue":"7","key":"3177_CR113","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/cancers17071169","volume":"17","author":"V Quagliariello","year":"2025","unstructured":"Quagliariello V, Berretta M, Bisceglia I, Giacobbe I, Iovine M, Barbato M, et al. In the era of cardiovascular\u2013kidney\u2013metabolic syndrome in cardio-oncology: from pathogenesis to prevention and therapy. Cancers (Basel). 2025;17(7):1169.","journal-title":"Cancers (Basel)"},{"key":"3177_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173444","volume":"884","author":"H Kang","year":"2020","unstructured":"Kang H, Zhang J, Zhang X, Qin G, Wang K, Deng Z, et al. Effects of sacubitril\/valsartan in patients with heart failure and chronic kidney disease: a meta-analysis. Eur J Pharmacol. 2020;884:173444.","journal-title":"Eur J Pharmacol"},{"issue":"23","key":"3177_CR115","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al. Effect of Finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383(23):2219\u201329.","journal-title":"N Engl J Med"},{"issue":"6","key":"3177_CR116","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","volume":"43","author":"R Agarwal","year":"2022","unstructured":"Agarwal R, Filippatos G, Pitt B, Anker SD, Rossing P, Joseph A, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43(6):474\u201384.","journal-title":"Eur Heart J"},{"issue":"9","key":"3177_CR117","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/13543784.2023.2263354","volume":"32","author":"I Forzano","year":"2023","unstructured":"Forzano I, Wilson S, Lombardi A, Jankauskas SS, Kansakar U, Mone P, et al. SGLT2 inhibitors: an evidence-based update on cardiovascular implications. Expert Opin Investig Drugs. 2023;32(9):839\u201347.","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"3177_CR118","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s40256-024-00687-9","volume":"24","author":"BD Beers","year":"2024","unstructured":"Beers BD, Chebrolu B, Stern GM, Buckley LF, Vaduganathan M, Bhatt DL, et al. SGLT2 inhibitor prescribing in cardiovascular\u2013kidney\u2013metabolic syndrome. Am J Cardiovasc Drugs. 2024;24(6):841\u20134.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1","key":"3177_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01506-8","volume":"21","author":"P Paolisso","year":"2022","unstructured":"Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F, et al. Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry. Cardiovasc Diabetol. 2022;21(1):77.","journal-title":"Cardiovasc Diabetol"},{"key":"3177_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110766","volume":"202","author":"P Paolisso","year":"2023","unstructured":"Paolisso P, Bergamaschi L, Cesaro A, Gallinoro E, Gragnano F, Sardu C, et al. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: insight from SGLT2-I AMI PROTECT registry. Diabetes Res Clin Pract. 2023;202:110766.","journal-title":"Diabetes Res Clin Pract"},{"issue":"15","key":"3177_CR121","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436\u201346.","journal-title":"N Engl J Med"},{"issue":"1","key":"3177_CR122","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1124\/jpet.121.001251","volume":"384","author":"P Mone","year":"2023","unstructured":"Mone P, Lombardi A, Kansakar U, Varzideh F, Jankauskas SS, Pansini A, et al. Empagliflozin improves the MicroRNA signature of endothelial dysfunction in patients with heart failure with preserved ejection fraction and diabetes. J Pharmacol Exp Ther. 2023;384(1):116\u201322.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"3177_CR123","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3390\/antiox14060701","volume":"14","author":"J Guerrero-Mauvecin","year":"2025","unstructured":"Guerrero-Mauvecin J, Villar-Gomez N, Mino-Izquierdo L, Povo-Retana A, Ramos AM, Ruiz-Hurtado G, et al. Antioxidant effects of SGLT2 inhibitors on cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome. Antioxidants (Basel). 2025;14(6):701.","journal-title":"Antioxidants (Basel)"},{"issue":"10","key":"3177_CR124","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.hlc.2025.07.005","volume":"34","author":"MA Allahwala","year":"2025","unstructured":"Allahwala MA, Marathe CS, Nelson AJ, Psaltis PJ, Marathe JA. Established and emerging therapies for cardiovascular\u2013kidney\u2013metabolic syndrome: harnessing the benefits of SGLT-2 inhibitors, GLP-1 receptor agonists, and beyond. Heart Lung Circ. 2025;34(10):995\u20131005.","journal-title":"Heart Lung Circ"},{"issue":"8","key":"3177_CR125","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/biomedicines13081924","volume":"13","author":"A Gajjar","year":"2025","unstructured":"Gajjar A, Raju AK, Gajjar A, Menon M, Shah SAY, Dani S, et al. SGLT2 inhibitors and GLP-1 receptor agonists in cardiovascular\u2013kidney\u2013metabolic syndrome. Biomedicines. 2025;13(8):1924.","journal-title":"Biomedicines"},{"issue":"12","key":"3177_CR126","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/ajhp\/zxaf053","volume":"82","author":"L Salama","year":"2025","unstructured":"Salama L, Sinn L. On the front lines of cardiovascular\u2013kidney\u2013metabolic syndrome: review of GLP-1 and dual GLP-1\/GIP receptor agonists in CV and kidney health. Am J Health Syst Pharm. 2025;82(12):693\u2013709.","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"3177_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2025.02.005","volume":"138","author":"A Babar","year":"2025","unstructured":"Babar A. Urgent call for targeted interventions in Cardiovascular\u2013kidney\u2013metabolic Syndrome. Am J Med. 2025;138(8):e162.","journal-title":"Am J Med"},{"issue":"3","key":"3177_CR128","doi-asserted-by":"publisher","DOI":"10.31083\/RCM26580","volume":"26","author":"X Cai","year":"2025","unstructured":"Cai X, Li T. Social determinants of health in the development of cardiovascular\u2013kidney\u2013metabolic syndrome. Rev Cardiovasc Med. 2025;26(3):26580.","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"3177_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-02032-9","volume":"17","author":"Y Xin","year":"2025","unstructured":"Xin Y, Qian X, Yang Y. Associations between sarcopenic obesity and the risk of Cardiovascular\u2013kidney\u2013metabolic Syndrome progression: insights from the China health and retirement longitudinal study. Diabetol Metab Syndr. 2025;17(1):460.","journal-title":"Diabetol Metab Syndr"},{"key":"3177_CR130","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1038\/s41598-025-32546-1","volume":"16","author":"W Li","year":"2025","unstructured":"Li W, Lou F, Liu X, Ye W, Lai Y, Liang Z, et al. Long-term exposure to ambient air pollution and incident cardiovascular disease in adults with cardiovascular\u2013kidney\u2013metabolic stages 0\u20133: a nationwide prospective cohort study in China. Sci Rep. 2025;16:2707.","journal-title":"Sci Rep"},{"key":"3177_CR131","doi-asserted-by":"crossref","unstructured":"Fu X, Sun W, Zhang Z, Gao J, Guo M, Wang R. Effect of physical activity volume on all-cause mortality in patients with cardiovascular\u2013kidney\u2013metabolic syndrome: evidence from the China health and retirement longitudinal study. Postgrad Med J. 2025.","DOI":"10.1093\/postmj\/qgaf205"},{"issue":"1","key":"3177_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05300-8","volume":"25","author":"J Liu","year":"2025","unstructured":"Liu J, Xu W, Zhang Y, Jia Y, Bai S, Er L, et al. Changes in the estimated glucose disposal rate and incident cardiovascular disease in patients with Cardiovascular\u2013kidney\u2013metabolic Syndrome stages 0-3: a prospective cohort study in China. BMC Cardiovasc Disord. 2025;25(1):889.","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"3177_CR133","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-109437","volume":"15","author":"J Wu","year":"2025","unstructured":"Wu J, Zuo Q, Zhang W, Liu J, Fang S, Li P, et al. Using electronic health records to improve cardiovascular\u2013kidney\u2013metabolic health: a protocol for the China Cardiovascular\u2013kidney\u2013metabolic Cohort-WeinAn REsearch (CKM-CARE). BMJ Open. 2025;15(11):e109437.","journal-title":"BMJ Open"},{"issue":"1","key":"3177_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05295-2","volume":"25","author":"Z Li","year":"2025","unstructured":"Li Z, Ren W, Li X, Duan R, Gao L, Li J, et al. Association between 10-year atherosclerotic cardiovascular disease risk score and incident cardiovascular events across stages 0-3 of Cardiovascular\u2013kidney\u2013metabolic Syndrome: evidence from the China health and retirement longitudinal study (CHARLS). BMC Cardiovasc Disord. 2025;25(1):812.","journal-title":"BMC Cardiovasc Disord"},{"key":"3177_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1604270","volume":"12","author":"C Huang","year":"2025","unstructured":"Huang C, Jia J, He Y. The nonlinear association between the triglyceride glucose-waist-to-height ratio index and cardiovascular disease among middle-aged and older adults in China with Cardiovascular\u2013kidney\u2013metabolic Syndrome stages 0-3. Front Cardiovasc Med. 2025;12:1604270.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"3177_CR136","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2025.05.030","volume":"86","author":"D He","year":"2025","unstructured":"He D, Zhang X, Li C, Yang C, Yu M, Wang J, et al. Rising prevalence of Cardiovascular\u2013kidney\u2013metabolic Syndrome in China, 2010\u20132019: national cross-sectional surveys. J Am Coll Cardiol. 2025;86(3):213\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"3177_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1612121","volume":"12","author":"X Zhou","year":"2025","unstructured":"Zhou X, Liu Y, Peng J, Zhou X, Wei H. The role of triglyceride-glucose index in the progression of Cardiovascular\u2013kidney\u2013metabolic Syndrome: findings from the China health and retirement longitudinal study. Front Cardiovasc Med. 2025;12:1612121.","journal-title":"Front Cardiovasc Med"},{"issue":"13","key":"3177_CR138","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/eurjpc\/zwaf248","volume":"32","author":"X Ding","year":"2025","unstructured":"Ding X, Tian J, Chang X, Liu J, Wang G. Association between remnant cholesterol and the risk of Cardiovascular\u2013kidney\u2013metabolic Syndrome progression: insights from the China Health and Retirement Longitudinal Study. Eur J Prev Cardiol. 2025;32(13):1157\u201365.","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"3177_CR139","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jacasi.2025.05.007","volume":"5","author":"M Guo","year":"2025","unstructured":"Guo M. Cardiovascular\u2013kidney\u2013metabolic Syndrome in China: a nationwide wake-up call. JACC Asia. 2025;5(7):911\u20133.","journal-title":"JACC Asia"},{"issue":"1","key":"3177_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02735-3","volume":"24","author":"M Li","year":"2025","unstructured":"Li M, Xu M, Ding Y, Lin H, Qin G, Wang T, et al. Life\u2019s Essential 8 cardiovascular health, Cardiovascular\u2013kidney\u2013metabolic Syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China. Cardiovasc Diabetol. 2025;24(1):197.","journal-title":"Cardiovasc Diabetol"},{"key":"3177_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1554032","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu H, Mao S, Zhao Y, Dong L, Wang Y, Lv C, et al. Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage Cardiovascular\u2013kidney\u2013metabolic Syndrome: evidence from the China Health and Retirement Longitudinal Study. Front Endocrinol (Lausanne). 2025;16:1554032.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3177_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s41043-025-00897-0","volume":"44","author":"X Xu","year":"2025","unstructured":"Xu X, Li X, Li X, Xue B, Zheng X, Xiao S, et al. Prediction of depression risk in middle-aged and elderly Cardiovascular\u2013kidney\u2013metabolic Syndrome patients by social and environmental determinants of health: an interpretable machine learning approach using longitudinal data from China. J Health Popul Nutr. 2025;44(1):187.","journal-title":"J Health Popul Nutr"},{"issue":"3 Pt 1","key":"3177_CR143","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jacasi.2024.12.003","volume":"5","author":"H Zhang","year":"2025","unstructured":"Zhang H, Hu Z, Wu J, Li Y, Jiang S, Jin L, et al. Prevalence of Cardiovascular\u2013kidney\u2013metabolic Syndrome stages among middle-aged and older adults in China. JACC Asia. 2025;5(3 Pt 1):393\u20135.","journal-title":"JACC Asia"},{"key":"3177_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1480576","volume":"12","author":"J Zhang","year":"2024","unstructured":"Zhang J, Huang H, Lin Z, Dong J, Zhang X, Gao J, et al. Associations between Cardiovascular\u2013kidney\u2013metabolic Syndrome and disability in activities of daily living: a nationwide longitudinal study among the middle-aged and older adults in China. Front Public Health. 2024;12:1480576.","journal-title":"Front Public Health"},{"issue":"7","key":"3177_CR145","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jacasi.2025.04.007","volume":"5","author":"C Zheng","year":"2025","unstructured":"Zheng C, Cai A, Sun M, Wang X, Song Q, Pei X, et al. Prevalence and mortality of Cardiovascular\u2013kidney\u2013metabolic Syndrome in China: a nationwide population-based study. JACC Asia. 2025;5(7):898\u2013910.","journal-title":"JACC Asia"},{"issue":"1","key":"3177_CR146","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2446656","volume":"47","author":"Z Shang","year":"2025","unstructured":"Shang Z, Feng ST, Qian H, Deng ZL, Wang Y, Gao YM. The impact of the triglyceride-glucose index on the deterioration of kidney function in patients with Cardiovascular\u2013kidney\u2013metabolic Syndrome: insight from a large cohort study in China. Ren Fail. 2025;47(1):2446656.","journal-title":"Ren Fail"},{"issue":"9","key":"3177_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102084","volume":"4","author":"R Chang","year":"2025","unstructured":"Chang R, Javed Z, Ostrominski JW, Philip J, Khalid SB, Ogungbe O, et al. Social determinants of health and mortality in Cardiovascular\u2013kidney\u2013metabolic Syndrome. JACC Adv. 2025;4(9):102084.","journal-title":"JACC Adv"},{"issue":"1","key":"3177_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-04812-7","volume":"25","author":"Q Yang","year":"2025","unstructured":"Yang Q, Shi P, Pan L, Huang Z. Social determinants of health (SDOH) associated with the risk of all-cause mortality and life expectancy in US adults with cardiovascular\u2013kidney\u2013metabolic syndrome: a NHANES 2001-2018 cohort study. BMC Cardiovasc Disord. 2025;25(1):369.","journal-title":"BMC Cardiovasc Disord"},{"issue":"10","key":"3177_CR149","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.040269","volume":"14","author":"CM Baker-Smith","year":"2025","unstructured":"Baker-Smith CM, Gauen AM, Petito LC, Khan SS, Allen NB. Prevalence of cardiovascular\u2013kidney\u2013metabolic stages in US adolescents and relationship to social determinants of health. J Am Heart Assoc. 2025;14(10):e040269.","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"3177_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0033291724002381","volume":"54","author":"X Huang","year":"2024","unstructured":"Huang X, Liang J, Zhang J, Fu J, Xie W, Zheng F. Association of cardiovascular\u2013kidney\u2013metabolic health and social connection with the risk of depression and anxiety. Psychol Med. 2024;54(15):1\u20139.","journal-title":"Psychol Med"},{"issue":"1","key":"3177_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-73974-9","volume":"14","author":"A Cotton","year":"2024","unstructured":"Cotton A, Salerno P, Deo SV, Virani S, Nasir K, Neeland I, et al. The association between county-level premature cardiovascular mortality related to cardio-kidney-metabolic disease and the social determinants of health in the US. Sci Rep. 2024;14(1):24984.","journal-title":"Sci Rep"},{"issue":"16","key":"3177_CR152","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036518","volume":"13","author":"AK April-Sanders","year":"2024","unstructured":"April-Sanders AK. Integrating social determinants of health in the management of cardiovascular\u2013kidney\u2013metabolic syndrome. J Am Heart Assoc. 2024;13(16):e036518.","journal-title":"J Am Heart Assoc"},{"key":"3177_CR153","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/jamacardio.2025.5305","volume":"11","author":"LA Mounsey","year":"2026","unstructured":"Mounsey LA, Chitsazan M, Shi I, Ribeiro PH, Parekh JK, Roshandelpoor A, et al. Cardiovascular\u2013kidney\u2013metabolic medication eligibility across national survey, community-based, and ambulatory healthcare samples. JAMA Cardiol. 2026;11:250.","journal-title":"JAMA Cardiol"},{"key":"3177_CR154","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13098-025-02030-x","volume":"18","author":"Q Huang","year":"2025","unstructured":"Huang Q, Luo X, Yang T, Qing X, Zhang X, Xiu M, et al. Longitudinal changes in frailty, insulin resistance and incident cardiovascular-kidney- metabolic syndrome progression in middle-aged and older adults: evidence from CHARLS. Diabetol Metab Syndr. 2025;18:38.","journal-title":"Diabetol Metab Syndr"},{"issue":"24","key":"3177_CR155","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.045192","volume":"14","author":"P Shi","year":"2025","unstructured":"Shi P, Lou C, Fang J, Song Y. Adverse life events across the life course and the risk of new-onset cardiovascular\u2013kidney\u2013metabolic multimorbidity in middle-aged and older adults: longitudinal evidence from CHARLS. J Am Heart Assoc. 2025;14(24):e045192.","journal-title":"J Am Heart Assoc"},{"key":"3177_CR156","doi-asserted-by":"crossref","unstructured":"Wang Y, Yu Q. METS-IR predicts new-onset stroke in older adults with stages 0\u20133 cardiovascular\u2013kidney\u2013metabolic syndrome: a prospective, multicohort, clinical study with statistical and machine learning. Diabetol Metab Syndr 2025.","DOI":"10.1186\/s13098-025-02033-8"},{"key":"3177_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112988","volume":"230","author":"Y Li","year":"2025","unstructured":"Li Y, Luo Z, Zhang Z, Huang N, Xiao L, Li J, et al. Exploring the mediating role of TyG-related indicators in the relationship between biological aging and late-stage cardiovascular\u2013kidney\u2013metabolic in middle-aged and older adults. Diabetes Res Clin Pract. 2025;230:112988.","journal-title":"Diabetes Res Clin Pract"},{"key":"3177_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14176008","author":"Z Yang","year":"2025","unstructured":"Yang Z, Wu S, Li Y, Liu H, Zhao M, Xu Y, et al. Association of frailty status with staging and mortality risk of Cardiovascular\u2013kidney\u2013metabolic Syndrome in middle-aged and older populations: insights from the 1999-2018 National Health and Nutrition Examination Survey. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14176008.","journal-title":"J Clin Med"},{"key":"3177_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118915","volume":"303","author":"S Fan","year":"2025","unstructured":"Fan S, Hu H, Li Y, Deng Y, Wang S, Xian J, et al. Effects of ambient air pollution mixtures and household fuel use on progression to advanced cardiovascular\u2013kidney\u2013metabolic syndrome among middle-aged and older adults. Ecotoxicol Environ Saf. 2025;303:118915.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"4","key":"3177_CR160","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1177\/13872877251352204","volume":"106","author":"X Zheng","year":"2025","unstructured":"Zheng X, Lin S, Cai Z, Li J. Association between cardiovascular\u2013kidney\u2013metabolic syndrome and risk of low cognitive function in older adults: data from the NHANES 2011\u20132014. J Alzheimers Dis. 2025;106(4):1523\u201332.","journal-title":"J Alzheimers Dis"},{"key":"3177_CR161","doi-asserted-by":"crossref","unstructured":"Nakade T, Matsue Y, Ikeda Y, Maeda D, Kagiyama N, Fujimoto Y, Inoue H, Sunayama T, Dotare T, Jujo K et al. Association of cardiovascular\u2013kidney\u2013metabolic overlap with physical function and prognosis in older patients with heart failure: a post-hoc analysis of the FRAGILE-HF and SONIC-HF. Eur J Prev Cardiol 2025.","DOI":"10.1093\/eurjpc\/zwaf279"},{"issue":"5","key":"3177_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100112","volume":"12","author":"X Jiang","year":"2025","unstructured":"Jiang X, Bahorik AL, Dintica CS, Yaffe K. Cardiovascular\u2013kidney\u2013metabolic syndrome and incidence of dementia among older adults. J Prev Alzheimers Dis. 2025;12(5):100112.","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"3177_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02940-0","volume":"24","author":"MY Tan","year":"2025","unstructured":"Tan MY, Jiang ZN, Li YQ, Li ZY, Niu B. Association of estimated glucose disposition rate with aging acceleration and mortality risk in individuals with Cardiovascular\u2013kidney\u2013metabolic Syndrome: evidence from two large national population-based studies. Cardiovasc Diabetol. 2025;24(1):402.","journal-title":"Cardiovasc Diabetol"},{"key":"3177_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112437","volume":"228","author":"X Qi","year":"2025","unstructured":"Qi X, Sui J, Yang Z, Dahlen A, Zhang K, Wu B. Periodontitis, accelerated biological aging, and advanced stages in Cardiovascular\u2013kidney\u2013metabolic Syndrome in U.S. adults: a mediation analysis. Diabetes Res Clin Pract. 2025;228:112437.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"3177_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-025-01175-9","volume":"24","author":"J Ge","year":"2025","unstructured":"Ge J, Zhu L, Jiang S, Li W, Lin R, Wu J, et al. Association of dietary quality, biological aging, progression and mortality of Cardiovascular\u2013kidney\u2013metabolic Syndrome: insights from mediation and machine learning approaches. Nutr J. 2025;24(1):105.","journal-title":"Nutr J"},{"key":"3177_CR166","doi-asserted-by":"publisher","DOI":"10.1159\/000549744","author":"Q Lu","year":"2025","unstructured":"Lu Q, Shao J, Jin J, Wang F, Cao Z, Zheng Q, et al. Predicting stroke incidence using estimated glucose disposal rate index in the population with Cardiovascular\u2013kidney\u2013metabolic Syndrome stage 0-3 in the Chinese middle-aged and elderly population. Cardiorenal Med. 2025. https:\/\/doi.org\/10.1159\/000549744.","journal-title":"Cardiorenal Med"},{"issue":"9","key":"3177_CR167","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.70914","volume":"15","author":"M Sun","year":"2025","unstructured":"Sun M, Yang Q, Zhang R, Zhang X, Xu L, Pan P. Association between cumulative atherogenic index of plasma and new-onset stroke among middle-aged and elderly Chinese patients with stages 0\u20133 Cardiovascular\u2013kidney\u2013metabolic Syndrome: a longitudinal cohort study. Brain Behav. 2025;15(9):e70914.","journal-title":"Brain Behav"},{"key":"3177_CR168","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1540241","volume":"16","author":"Y Lin","year":"2025","unstructured":"Lin Y, Lv X, Shi C, Wang T, Jin Z, Jin Q, et al. Association between atherogenic index of plasma and future cardiovascular disease risk in middle-aged and elderly individuals with Cardiovascular\u2013kidney\u2013metabolic Syndrome stage 0-3. Front Endocrinol (Lausanne). 2025;16:1540241.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"3177_CR169","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeaf162","volume":"5","author":"S Taya","year":"2025","unstructured":"Taya S, Ejiri K, Kaneko H, Suzuki Y, Miyoshi T, Mizuno A, et al. Sex differences in the progression of Cardiovascular\u2013kidney\u2013metabolic Syndrome. Eur Heart J Open. 2025;5(6):oeaf162.","journal-title":"Eur Heart J Open"},{"issue":"17","key":"3177_CR170","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/eurjpc\/zwaf050","volume":"32","author":"C Yang","year":"2025","unstructured":"Yang C, Li Z, Sui Y, Long T, Cheng S, Guo X, et al. Sex differences in Cardiovascular\u2013kidney\u2013metabolic risk factors associated with degenerative valvular heart disease. Eur J Prev Cardiol. 2025;32(17):1705\u201315.","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"3177_CR171","doi-asserted-by":"publisher","first-page":"e3303","DOI":"10.1210\/clinem\/dgaf059","volume":"110","author":"L Jiang","year":"2025","unstructured":"Jiang L, Zhou L, Liu J, Wang Y, Wang G. Sex differences in the association between thyroid hormone sensitivity and Cardiovascular\u2013kidney\u2013metabolic Syndrome. J Clin Endocrinol Metab. 2025;110(10):e3303\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3177_CR172","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/ATVBAHA.124.321629","volume":"45","author":"H Ji","year":"2025","unstructured":"Ji H, Sabanayagam C, Matsushita K, Cheng CY, Rim TH, Sheng B, et al. Sex differences in Cardiovascular\u2013kidney\u2013metabolic Syndrome: 30-year US trends and mortality risks-brief report. Arterioscler Thromb Vasc Biol. 2025;45(1):157\u201361.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3177_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13154354","author":"M Guldan","year":"2024","unstructured":"Guldan M, Unlu S, Abdel-Rahman SM, Ozbek L, Gaipov A, Covic A, et al. Understanding the role of sex hormones in Cardiovascular Kidney Metabolic Syndrome: toward personalized therapeutic approaches. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13154354.","journal-title":"J Clin Med"},{"key":"3177_CR174","doi-asserted-by":"publisher","DOI":"10.2196\/57920","volume":"10","author":"Y Ding","year":"2024","unstructured":"Ding Y, Wu X, Cao Q, Huang J, Xu X, Jiang Y, et al. Gender disparities in the association between educational attainment and Cardiovascular\u2013kidney\u2013metabolic Syndrome: cross-sectional study. JMIR Public Health Surveill. 2024;10:e57920.","journal-title":"JMIR Public Health Surveill"},{"issue":"1","key":"3177_CR175","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2025.2589608","volume":"41","author":"SA Thomas","year":"2025","unstructured":"Thomas SA, Kempegowda P, Armeni E. Menopause as a critical window for Cardiovascular\u2013kidney\u2013metabolic Syndrome prevention: a call for integrated women\u2019s health approaches. Gynecol Endocrinol. 2025;41(1):2589608.","journal-title":"Gynecol Endocrinol"},{"key":"3177_CR176","doi-asserted-by":"crossref","unstructured":"Pabon MA, Ostrominski JW, Wang X, Claggett BL, Lo KB, Filippatos G, Desai AS, Jhund PS, Henderson A, Lam CSP et al. Sex differences in cardiovascular\u2013kidney\u2013metabolic syndrome: the FINE-HEART pooled analysis. Eur Heart J. 2026.","DOI":"10.1093\/eurheartj\/ehag162"},{"issue":"12","key":"3177_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2025.102710","volume":"13","author":"S Huang","year":"2025","unstructured":"Huang S, Tamaroff J, Farber-Eger E, Chow N, Siddiqi HK, Brinkley DM, et al. Cardiovascular\u2013kidney\u2013metabolic Disease burden in children and adults following heart transplantation. JACC Heart Fail. 2025;13(12):102710.","journal-title":"JACC Heart Fail"},{"key":"3177_CR178","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jpeds.2017.08.047","volume":"191","author":"HP Patel","year":"2017","unstructured":"Patel HP, Saland JM, Ng DK, Jiang S, Warady BA, Furth SL, et al. Waist circumference and body mass index in children with chronic kidney disease and metabolic, cardiovascular, and renal outcomes. J Pediatr. 2017;191:133\u20139.","journal-title":"J Pediatr"},{"issue":"9","key":"3177_CR179","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2215\/CJN.07100810","volume":"6","author":"SL Furth","year":"2011","unstructured":"Furth SL, Abraham AG, Jerry-Fluker J, Schwartz GJ, Benfield M, Kaskel F, et al. Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(9):2132\u201340.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"3177_CR180","doi-asserted-by":"publisher","first-page":"693","DOI":"10.7326\/M23-1874","volume":"177","author":"FS Yen","year":"2024","unstructured":"Yen FS, Hwu CM, Liu JS, Wu YL, Chong K, Hsu CC. Sodium-glucose cotransporter-2 inhibitors and the risk for dialysis and cardiovascular disease in patients with stage 5 chronic kidney disease. Ann Intern Med. 2024;177(6):693\u2013700.","journal-title":"Ann Intern Med"},{"key":"3177_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102465","author":"S Kumar","year":"2026","unstructured":"Kumar S, Anderson J, Coviello A, Lopez-Jimenez F, Bakris G. The role of glucagon-like peptide-1 receptor agonists in the treatment of cardiovascular\u2013kidney\u2013metabolic syndrome. JACC Adv. 2026. https:\/\/doi.org\/10.1016\/j.jacadv.2025.102465.","journal-title":"JACC Adv"},{"key":"3177_CR182","doi-asserted-by":"crossref","unstructured":"Hu M, Gong Z, Li X, Xia J, Yin C. Associations of lipid-lowering drugs with cardiovascular\u2013kidney\u2013metabolic syndrome: a drug-target Mendelian randomization study. J Clin Lipidol. 2025.","DOI":"10.1016\/j.jacl.2025.10.076"},{"key":"3177_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112892","volume":"210","author":"M Dong","year":"2025","unstructured":"Dong M, Chen X, Liu J, Li C. Non-conventional lipid parameters predict the risk of rapid kidney function decline in patients with cardiovascular\u2013kidney\u2013metabolic syndrome: the first cohort study evidence from CHARLS. Exp Gerontol. 2025;210:112892.","journal-title":"Exp Gerontol"},{"issue":"1","key":"3177_CR184","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01919-x","volume":"17","author":"Y Pan","year":"2025","unstructured":"Pan Y, Du B, Feng L, Bi J. Comparative analysis of 16 baseline obesity and lipid-related indices for cardiovascular disease risk prediction in adults with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0-3: a nationwide prospective cohort study. Diabetol Metab Syndr. 2025;17(1):343.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3177_CR185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000547533","volume":"15","author":"Z Fang","year":"2025","unstructured":"Fang Z, Yuan J, Qiu J, Liu Q, He R, Zheng D, et al. Association between visceral lipid accumulation indicators and advanced cardiovascular\u2013kidney\u2013metabolic syndrome: a cross-sectional study based on NHANES 1999\u20132018. Cardiorenal Med. 2025;15(1):1\u201330.","journal-title":"Cardiorenal Med"},{"key":"3177_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2025.156452","volume":"175","author":"S Wei","year":"2026","unstructured":"Wei S, Shu Z, Li X, Zhong S, Xiao L, Shen R, et al. Air pollution exacerbates cardiovascular\u2013kidney\u2013metabolic syndrome and sarcopenia comorbidity via shared genetic-epigenetic mechanisms: a multi-omics and Mendelian randomization study. Metabolism. 2026;175:156452.","journal-title":"Metabolism"},{"issue":"1","key":"3177_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100325","volume":"13","author":"YP Zhang","year":"2026","unstructured":"Zhang YP, Gao JW, Liao GH, Gao QY, Huang ZG, Zeng CR, et al. Cardiovascular\u2013kidney\u2013metabolic health, genetic susceptibility, and the risk of dementia: a prospective cohort study. J Prev Alzheimers Dis. 2026;13(1):100325.","journal-title":"J Prev Alzheimers Dis"},{"key":"3177_CR188","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20852","author":"G Zheng","year":"2025","unstructured":"Zheng G, Zhang Y, Su H, Yang H, Ma Z, Li L, et al. Cardiovascular\u2013kidney\u2013metabolic health, genetic predisposition and incident risk of psoriasis. J Eur Acad Dermatol Venereol. 2025. https:\/\/doi.org\/10.1111\/jdv.20852.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3177_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103588","volume":"81","author":"Y Chen","year":"2025","unstructured":"Chen Y, Wu S, Liu H, Zhong Z, Bucci T, Wang Y, et al. Role of oxidative balance score in staging and mortality risk of cardiovascular\u2013kidney\u2013metabolic syndrome: insights from traditional and machine learning approaches. Redox Biol. 2025;81:103588.","journal-title":"Redox Biol"},{"key":"3177_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.119515","volume":"309","author":"W Wen","year":"2025","unstructured":"Wen W, Liu Z, Li L, Qiu F, Zhang H, Cao Y, et al. Multimodal mechanisms of di (2-ethylhexyl) phthalate-induced Cardiovascular\u2013kidney\u2013metabolic Syndrome: integrating epidemiology, network toxicology and experimental validation. Ecotoxicol Environ Saf. 2025;309:119515.","journal-title":"Ecotoxicol Environ Saf"},{"key":"3177_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118885","volume":"303","author":"Y He","year":"2025","unstructured":"He Y, Zhou X, Huang W, Wu Y, Zhang Z, Jin Y, et al. Cadmium exposure and advanced Cardiovascular\u2013kidney\u2013metabolic Syndrome: an integrated multi-organ perspective based on epidemiology and adverse outcome pathways. Ecotoxicol Environ Saf. 2025;303:118885.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"3177_CR192","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11883-025-01358-z","volume":"27","author":"F Askarizadeh","year":"2025","unstructured":"Askarizadeh F, Almahmeed W, Abass KS, Virani S, Sahebkar A. Statins as modulators of epithelial to mesenchymal transition in Cardiovascular\u2013kidney\u2013metabolic Syndrome: a comprehensive review of mechanisms and therapeutic implications. Curr Atheroscler Rep. 2025;27(1):114.","journal-title":"Curr Atheroscler Rep"},{"key":"3177_CR193","volume":"43","author":"Y Hua","year":"2025","unstructured":"Hua Y, Huang Z, Yin Y, Song R, Meng X. Genetic architecture and mechanisms shared between kidney and ureteral stones, cardiovascular diseases, and metabolic syndrome: a comprehensive GWAS analysis. Biochem Biophys Rep. 2025;43:102116.","journal-title":"Biochem Biophys Rep"},{"key":"3177_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.nuclcard.2025.102299","volume":"51","author":"JM Brown","year":"2025","unstructured":"Brown JM, Huck DM. Total-body positron emission tomography: investigating mechanisms in Cardiovascular\u2013kidney\u2013metabolic Syndrome. J Nucl Cardiol. 2025;51:102299.","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"3177_CR195","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70046","volume":"17","author":"M Chen","year":"2025","unstructured":"Chen M, Cai S, Jia Q, Suo Y, Tang Y, Shi Y, et al. Inverse relationship between serum carotenoid levels and Cardiovascular\u2013kidney\u2013metabolic Syndrome among the general adult population. J Diabetes. 2025;17(2):e70046.","journal-title":"J Diabetes"},{"key":"3177_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1557491","volume":"12","author":"H Yu","year":"2025","unstructured":"Yu H, Liu Y, Zhang T, Guan Z, Li P. Association between dietary inflammatory index score and Cardiovascular\u2013kidney\u2013metabolic Syndrome: a cross-sectional study based on NHANES. Front Nutr. 2025;12:1557491.","journal-title":"Front Nutr"},{"issue":"1","key":"3177_CR197","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-025-01127-3","volume":"24","author":"C Zhao","year":"2025","unstructured":"Zhao C, Lin M, Yang Y, Yang H, Gao Z, Yan Z, et al. Association between dietary inflammatory index and Cardiovascular\u2013kidney\u2013metabolic Syndrome risk: a cross-sectional study. Nutr J. 2025;24(1):60.","journal-title":"Nutr J"},{"issue":"5","key":"3177_CR198","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-093383","volume":"15","author":"S Zhao","year":"2025","unstructured":"Zhao S, Duan J. Association of the triglyceride-glucose index with all-cause and cardiovascular mortality among individuals with Cardiovascular\u2013kidney\u2013metabolic Syndrome: a population-based cohort study using data from the US National Health and Nutrition Examination Survey, 1999\u20132018. BMJ Open. 2025;15(5):e093383.","journal-title":"BMJ Open"},{"issue":"1","key":"3177_CR199","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02742-4","volume":"24","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Cao Z, Teng J, Lu Q, Huang P, Zhou J. Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular\u2013kidney\u2013metabolic Syndrome. Cardiovasc Diabetol. 2025;24(1):183.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"3177_CR200","doi-asserted-by":"publisher","first-page":"H1244","DOI":"10.1152\/ajpheart.00548.2025","volume":"329","author":"A Eirin","year":"2025","unstructured":"Eirin A, Chade AR. When in doubt, pig it out: a versatile translational platform to study CKD, HFpEF, and CKM syndrome. Am J Physiol Heart Circ Physiol. 2025;329(5):H1244\u201352.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3177_CR201","doi-asserted-by":"crossref","unstructured":"Lu Y, Ge J, Zhu L, Wang L, Wu J, Dong F, Deng J. Cardiometabolic-kidney indices and machine learning model for predicting all-cause mortality in patients with cardiovascular\u2013kidney\u2013metabolic syndrome: a longitudinal cohort study. Am J Nephrol. 2025;1\u201328.","DOI":"10.1159\/000549578"},{"key":"3177_CR202","doi-asserted-by":"crossref","unstructured":"Xue M, Chang H, Wang BC, Ma N, Zhang XQ, Wang XQ, Niu WQ, Dong XQ, Chang CH. Development of an explainable machine learning model for cardiovascular\u2013kidney\u2013metabolic syndrome prediction based on dietary antioxidants in a national population. J Vasc Res. 2025;1\u201327.","DOI":"10.1159\/000549326"},{"issue":"10","key":"3177_CR203","doi-asserted-by":"publisher","DOI":"10.1111\/1750-3841.70634","volume":"90","author":"Z Yan","year":"2025","unstructured":"Yan Z, Xu Y, Du X. Gut microbiota-modulating diets attenuate Cardiovascular\u2013kidney\u2013metabolic Syndrome via inflammatory mediation: insights from NHANES and machine learning model. J Food Sci. 2025;90(10):e70634.","journal-title":"J Food Sci"},{"key":"3177_CR204","first-page":"10","volume":"360","author":"S Lotfollahzadeh","year":"2025","unstructured":"Lotfollahzadeh S, Paul H, Bonifacio J, Almiron R, Hockestra I, Przekop K, et al. A murine model of cardiovascular\u2013kidney\u2013metabolic syndrome demonstrates compromised limb function in the ischemic hind limb. Kidney. 2025;360:10.","journal-title":"Kidney"},{"issue":"1","key":"3177_CR205","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12933-026-03173-5","volume":"25","author":"J Hua","year":"2026","unstructured":"Hua J, Wang Q, Liu Y, Luo S, Shi A, Yan Z, Zhang J, Gu W, Zhu L, Zhang Y, Zhang L, Yu P, Liu X, Wang W. Sweet relief: exploring mechanisms and therapeutic approaches of sodium-glucose cotransporter-2 inhibitors in cardiovascular-kidney metabolic syndrome. Cardiovasc Diabetol. 2026;25(1):120. https:\/\/doi.org\/10.1186\/s12933-026-03173-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3177_CR206","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40842-025-00262-4","volume":"11","author":"L Geng","year":"2025","unstructured":"Geng L, Diao X, Yu HJ, Xu A. Association of hemoglobin glycation index with the severity and mortality of cardiovascular-kidney-metabolic syndrome: a population-based cohort study. Cardiovasc Diabetol Endocrinol Rep. 2025;11(1):46. https:\/\/doi.org\/10.1186\/s40842-025-00262-4.","journal-title":"Cardiovasc Diabetol Endocrinol Rep"},{"key":"3177_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2025.180003","volume":"993","author":"Z Zheng","year":"2025","unstructured":"Zheng Z, Xu Y, Kang N, Dong Y, Wang X, Zhang L, et al. Assessing the effect of perfluoroalkyl and polyfluoroalkyl substances on Cardiovascular\u2013kidney\u2013metabolic Syndrome: insights from an interpretable machine learning model. Sci Total Environ. 2025;993:180003.","journal-title":"Sci Total Environ"},{"key":"3177_CR208","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jad.2025.04.139","volume":"383","author":"B Zha","year":"2025","unstructured":"Zha B, Cai A, Yu H, Wang Z. Development and validation of a predictive model for depression in patients with advanced stage of Cardiovascular\u2013kidney\u2013metabolic Syndrome. J Affect Disord. 2025;383:32\u201340.","journal-title":"J Affect Disord"},{"key":"3177_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.100944","volume":"21","author":"S Rajagopalan","year":"2025","unstructured":"Rajagopalan S, Adarquah-Yiadom J, McClain F, Ansah JP, Osborne H, Nicholson K, et al. The community health worker model for Cardiovascular Kidney Metabolic Syndrome: a new paradigm for high value care. Am J Prev Cardiol. 2025;21:100944.","journal-title":"Am J Prev Cardiol"},{"key":"3177_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/nu16234105","author":"L Carvalho","year":"2024","unstructured":"Carvalho L, Tyden M, Shimari M, Zhuge Z, Schiffer TA, de Oliveira Monteiro MM, et al. Protective effects of the food supplement Flexovital in a model of Cardiovascular\u2013kidney\u2013metabolic Syndrome in mice. Nutrients. 2024. https:\/\/doi.org\/10.3390\/nu16234105.","journal-title":"Nutrients"},{"issue":"11","key":"3177_CR211","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41684-024-01457-5","volume":"53","author":"L Carvalho","year":"2024","unstructured":"Carvalho L, Shimari M, Boeder AM, Zhuge Z, Cai M, Leijding C, et al. A novel model of Cardiovascular\u2013kidney\u2013metabolic Syndrome combining unilateral nephrectomy and high-salt-sugar-fat diet in mice. Lab Anim (NY). 2024;53(11):336\u201346.","journal-title":"Lab Anim (NY)"},{"issue":"1","key":"3177_CR212","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02589-9","volume":"24","author":"G Zheng","year":"2025","unstructured":"Zheng G, Jin J, Wang F, Zheng Q, Shao J, Yao J, et al. Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with Cardiovascular\u2013kidney\u2013metabolic Syndrome stages 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):22.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3177_CR213","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-025-02593-z","volume":"24","author":"Y Hu","year":"2025","unstructured":"Hu Y, Liang Y, Li J, Li X, Yu M, Cui W. Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):40.","journal-title":"Cardiovasc Diabetol"},{"key":"3177_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133012","volume":"423","author":"Y Horiuchi","year":"2025","unstructured":"Horiuchi Y, Wettersten N, Tanabe K. A comprehensive impact of GLP1Ras on CKM syndrome. Int J Cardiol. 2025;423:133012.","journal-title":"Int J Cardiol"},{"key":"3177_CR215","doi-asserted-by":"publisher","first-page":"102755","DOI":"10.1016\/j.jchf.2025.102755","volume":"14","author":"A Shah","year":"2025","unstructured":"Shah A, McDermott J, Rao VN, Gupta M, Barnes SG, Green CL, et al. In-hospital virtual consultation to implement guideline-directed medical therapy for cardiovascular\u2013kidney\u2013metabolic disease: the IMPLEMENT-CRM randomized trial. JACC Heart Fail. 2025;14:102755.","journal-title":"JACC Heart Fail"},{"key":"3177_CR216","doi-asserted-by":"publisher","first-page":"102727","DOI":"10.1016\/j.jchf.2025.102727","volume":"14","author":"AS Bhatt","year":"2025","unstructured":"Bhatt AS, De Oliveira-Gomes D, Fiuzat M, Vaduganathan M, Hamo CE, Stockbridge N, et al. Assessing medical therapy optimization in cardiovascular\u2013kidney\u2013metabolic clinical trials: an initiative from the Heart Failure Collaboratory. JACC Heart Fail. 2025;14:102727.","journal-title":"JACC Heart Fail"},{"issue":"3","key":"3177_CR217","doi-asserted-by":"publisher","first-page":"223","DOI":"10.23736\/S0026-4806.25.09607-7","volume":"116","author":"C Pena","year":"2025","unstructured":"Pena C, Flores J, Nugent K. Cardiovascular\u2013kidney\u2013metabolic syndrome and treatment advances: A narrative review. Minerva Med. 2025;116(3):223\u201333.","journal-title":"Minerva Med"},{"issue":"Suppl 8(Suppl 8","key":"3177_CR218","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.70044","volume":"27","author":"K Yau","year":"2025","unstructured":"Yau K, Cherney DZI, Odutayo A. Biomarkers for Cardiovascular\u2013kidney\u2013metabolic Syndrome: clinical utility in diagnosis, screening, and treatment. Diabetes Obes Metab. 2025;27(Suppl 8(Suppl 8)):3\u20136.","journal-title":"Diabetes Obes Metab"},{"issue":"20","key":"3177_CR219","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jacc.2025.08.039","volume":"86","author":"JW Ostrominski","year":"2025","unstructured":"Ostrominski JW, Harrington J, Claggett BL, Filippatos G, Desai AS, Jhund PS, et al. Anthropometric measures, cardiovascular outcomes, and treatment effects of Finerenone in Cardiovascular\u2013kidney\u2013metabolic Disease: Pooled participant-level analysis of 3 global trials. J Am Coll Cardiol. 2025;86(20):1781\u2013801.","journal-title":"J Am Coll Cardiol"},{"key":"3177_CR220","doi-asserted-by":"publisher","first-page":"106512","DOI":"10.1016\/j.ejim.2025.106512","volume":"145","author":"DA Mei","year":"2025","unstructured":"Mei DA, Imberti JF, Vitolo M, Romiti GF, Corica B, Mantovani M, et al. Cardiovascular\u2013kidney\u2013metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry. Eur J Intern Med. 2025;145:106512.","journal-title":"Eur J Intern Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03177-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03177-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03177-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:02:12Z","timestamp":1781658132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03177-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":220,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3177"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03177-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}